What You Should Know:
– ZBiotics, the pioneers carving a new category of genetically engineered probiotics, today announced the close of its $12M Series A funding round, led by Spring Tide Capital. The oversubscribed round also includes participation by Access Capital, Seamless Capital, Goat Rodeo Capital, and Seaside Ventures.
– The company will use the funds to meet growing consumer demand, spearhead retail expansion, and drive continued research and development in a new sector, including bringing new genetically engineered probiotic products to market that address the unique and newly arising biological challenges of modern living.
ZBiotics Pioneers Genetically Engineered Probiotics to Address Modern Health Challenges
ZBiotics is the world’s first manufacturer of genetically engineered probiotics, specifically designed to enhance health by addressing the unique biological challenges of modern living. Founded by CEO and co-founder Zack Abbott, Ph.D., the company’s flagship product, the Pre-Alcohol Probiotic Drink, effectively breaks down acetaldehyde—an unwanted byproduct of alcohol consumption associated with the day-after effects of drinking.
Led by a team of dedicated Ph.D. scientists, ZBiotics employs a new approach to genetic engineering that is transparent, responsible, and tailored directly for consumers. By leveraging advanced biotechnology, ZBiotics enables consumers to actively engage in healthier living through probiotics engineered for specific use cases that solve real-world problems. The company’s innovative solutions go beyond traditional methods, providing sustainable and effective options that were previously unattainable without genetic engineering.
ZBiotics is fundamentally driven by the mission to improve health through modern biotechnology. The company’s offerings include:
– Flagship Product: The Pre-Alcohol Probiotic Drink mimics liver function by breaking down acetaldehyde, helping consumers feel better the day after drinking.
– Upcoming Products:
– A second probiotic focused on enhancing microbial diversity in the gut.
– Future developments targeting areas such as sleep, vaginal health, and athletic performance.
Utilizing funds from its Series A round, ZBiotics plans to develop and bring additional use-case probiotics to market. This investment will support the creation of new products using the same innovative technology behind the Pre-Alcohol Probiotic Drink, catering to consumers prioritizing various aspects of their health. Additionally, the funds will facilitate the launch of the ZBiotics brand into physical retail spaces, aligning with the company’s long-term vision to make “proudly GMO” products more accessible to those who benefit from their solutions.
By merging biotechnology with consumer goods, ZBiotics is trailblazing a new frontier in health and wellness. The company provides consumers with genetically engineered probiotics that offer effective, targeted health benefits, setting a new standard for sustainable and impactful health solutions.
“Off of the breakout success of their first product, ZBiotics has more than doubled sales every year, selling over 5 million units cumulatively and reaching company-wide profitability in 2023,” said Adam Ramada, co-managing partner of Spring Tide Capital. “We are thrilled to support the team as they continue to expand their revolutionary probiotic platform across many more exciting use cases that address everyday consumer pain points.”
